SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Uermösi, F. Zabel, V. Manolova, M. Bauer, R. R. Beerli, G. Senti, T. M. Kündig, P. Saudan, M. F. Bachmann, IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization, Allergy, 2014, 69, 3
  2. 2
    Mübeccel Akdis, Cezmi A. Akdis, Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens, Journal of Allergy and Clinical Immunology, 2014, 133, 3, 621

    CrossRef

  3. 3
    Willem van de Veen, Mübeccel Akdis, New Targets for Immune Modulation in Asthma, Current Treatment Options in Allergy, 2014, 1, 2, 171

    CrossRef

  4. 4
    Darío Antolín-Amérigo, Carmen Moreno Aguilar, Arantza Vega, Melchor Alvarez-Mon, Venom Immunotherapy: an Updated Review, Current Allergy and Asthma Reports, 2014, 14, 7

    CrossRef

  5. 5
    Ulrich R Müller, Arthur Helbling, Advances in Anaphylaxis Management, 2014,

    CrossRef

  6. 6
    Rima Rachid, Dale T. Umetsu, Immunological mechanisms for desensitization and tolerance in food allergy, Seminars in Immunopathology, 2012, 34, 5, 689

    CrossRef

  7. 7
    S. U. Patil, W. G. Shreffler, Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation, Clinical & Experimental Immunology, 2012, 167, 1
  8. 8
    Thomas Eiwegger, Saskia Gruber, Zsolt Szépfalusi, Cezmi A. Akdis, Novel developments in the mechanisms of immune tolerance to allergens, Human Vaccines & Immunotherapeutics, 2012, 8, 10, 1485

    CrossRef

  9. 9
    Wen Su, Wenwei Zhong, Yanjie Zhang, Zhenwei Xia, Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells, BMC Immunology, 2012, 13, 1, 34

    CrossRef

  10. 10
    Sevgi Keles, Elif Karakoc-Aydiner, Ahmet Ozen, Ayse Gul Izgi, Ayzer Tevetoglu, Tunc Akkoc, Nerin N. Bahceciler, Isil Barlan, A novel approach in allergen-specific immunotherapy: Combination of sublingual and subcutaneous routes, Journal of Allergy and Clinical Immunology, 2011, 128, 4, 808

    CrossRef

  11. 11
    M. Jutel, C. A. Akdis, Immunological mechanisms of allergen-specific immunotherapy, Allergy, 2011, 66, 6
  12. 12
    Cevdet Ozdemir, Umut Can Kucuksezer, Mübeccel Akdis, Cezmi A. Akdis, Specific immunotherapy and turning off the T cell: how does it work?, Annals of Allergy, Asthma & Immunology, 2011, 107, 5, 381

    CrossRef

  13. 13
    Tunc Akkoc, Mübeccel Akdis, Cezmi A. Akdis, Update in the Mechanisms of Allergen-Specific Immunotheraphy, Allergy, Asthma and Immunology Research, 2011, 3, 1, 11

    CrossRef

  14. 14
    Christina Uermösi, Roger R. Beerli, Monika Bauer, Vania Manolova, Klaus Dietmeier, Regula B. Buser, Thomas M. Kündig, Philippe Saudan, Martin F. Bachmann, Mechanisms of allergen-specific desensitization, Journal of Allergy and Clinical Immunology, 2010, 126, 2, 375

    CrossRef

  15. 15
    F. Ruëff, U. Jappe, B. Przybilla, Standards und Fallstricke der In-vitro-Diagnostik der Insektengiftallergie, Der Hautarzt, 2010, 61, 11, 938

    CrossRef

  16. 16
    Christine Loewenstein, Ralf S. Mueller, A review of allergen-specific immunotherapy in human and veterinary medicine, Veterinary Dermatology, 2009, 20, 2
  17. 17
    Jennifer M. Rolland, Leanne M. Gardner, Robyn E. O'Hehir, Allergen-related approaches to immunotherapy, Pharmacology & Therapeutics, 2009, 121, 3, 273

    CrossRef

  18. 18
    Mübeccel Akdis, Immune tolerance in allergy, Current Opinion in Immunology, 2009, 21, 6, 700

    CrossRef

  19. 19
    Franziska Ruëff, M. Beatrice Bilò, Marek Jutel, Holger Mosbech, Ulrich Müller, Bernhard Przybilla, Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy, Journal of Allergy and Clinical Immunology, 2009, 123, 1, 272

    CrossRef

  20. 20
    Mübeccel Akdis, Cezmi A. Akdis, Therapeutic manipulation of immune tolerance in allergic disease, Nature Reviews Drug Discovery, 2009, 8, 8, 645

    CrossRef

  21. 21
    Chia-Chun Hou, Craig E. Griffin, Peter B. Hill, Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines, Veterinary Dermatology, 2008, 19, 4
  22. 22
    Hassan S. El, A. Purohit, S. Spitzauer, V. Niederberger, R. Valenta, G. Pauli, Induction d’IgG spécifiques au cours d’une désensibilisation effectuée avec des allergènes recombinants, Revue Française d'Allergologie et d'Immunologie Clinique, 2008, 48, 1, 55

    CrossRef

  23. 23
    Mübeccel Akdis, Cezmi A. Akdis, Mechanisms of allergen-specific immunotherapy, Journal of Allergy and Clinical Immunology, 2007, 119, 4, 780

    CrossRef

  24. 24
    Louisa K. Wilcock, James N. Francis, Stephen R. Durham, IgE-Facilitated Antigen Presentation: Role in Allergy and the Influence of Allergen Immunotherapy, Immunology and Allergy Clinics of North America, 2006, 26, 2, 333

    CrossRef

  25. 25
    Mark Larché, Cezmi A. Akdis, Rudolf Valenta, Immunological mechanisms of allergen-specific immunotherapy, Nature Reviews Immunology, 2006, 6, 10, 761

    CrossRef

  26. 26
    M. Jutel, M. Akdis, K. Blaser, C. A. Akdis, Mechanisms of allergen specific immunotherapy – T-cell tolerance and more, Allergy, 2006, 61, 7
  27. 27
    Johan Verhagen, Kurt Blaser, Cezmi A. Akdis, Mübeccel Akdis, Mechanisms of Allergen-Specific Immunotherapy: T-Regulatory Cells and More, Immunology and Allergy Clinics of North America, 2006, 26, 2, 207

    CrossRef

  28. 28
    Mohamed H. Shamji, Louisa K. Wilcock, Petra A. Wachholz, Rebecca J. Dearman, Ian Kimber, Peter A. Wurtzen, Mark Larché, Stephen R. Durham, James N. Francis, The IgE-facilitated allergen binding (FAB) assay: Validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses, Journal of Immunological Methods, 2006, 317, 1-2, 71

    CrossRef

  29. 29
    Ulrich R Müller, Bee venom allergy in beekeepers and their family members, Current Opinion in Allergy and Clinical Immunology, 2005, 5, 4, 343

    CrossRef

  30. 30
    Jean-Charles Glérant, Philippe Martinez, Claude Guillaume, Vincent Jounieaux, Comparison of 2 maintenance doses (100 μg vs 200 μg) in Hymenoptera venom immunotherapy: influence of the maintenance dose on the immunologic response, Annals of Allergy, Asthma & Immunology, 2005, 94, 4, 451

    CrossRef

  31. 31
    B. M. Biló, F. Rueff, H. Mosbech, F. Bonifazi, J. N. G. Oude-Elberink, Diagnosis of Hymenoptera venom allergy, Allergy, 2005, 60, 11
  32. 32
    O. Pfaar, L. Klimek, I. Hansen, B. A. Stuck, K. Hörmann, Diagnostik und Therapie der Insektengiftallergie, HNO, 2005, 53, 12, 1099

    CrossRef

  33. 33
    U.R Müller, Allergies aux venins d’hyménoptères : perspectives de progrès dans le diagnostic et le traitement d’hyposensibilisation, Revue Française d'Allergologie et d'Immunologie Clinique, 2004, 44, 3, 281

    CrossRef

  34. 34
    C. L. Hardy, J. M. Rolland, R. E. O'Hehir, Blocking antibodies in allergen immunotherapy: the Yin and Yang, Clinical & Experimental Allergy, 2004, 34, 4
  35. 35
    S. G. A. Brown, M. A. Haas, J. A. Black, A. Parameswaran, G. M. Woods, R. J. Heddle, In vitro testing to diagnose venom allergy and monitor immunotherapy: a placebo-controlled, crossover trial, Clinical & Experimental Allergy, 2004, 34, 5
  36. 36
    Petra A Wachholz, Stephen R Durham, Mechanisms of immunotherapy: IgG revisited, Current Opinion in Allergy and Clinical Immunology, 2004, 4, 4, 313

    CrossRef

  37. 37
    F. Ruëff, H. Wolf, J. Schnitker, J. Ring, B. Przybilla, Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations, Allergy, 2004, 59, 6
  38. 38
    Jean-Marc Fellrath, Alexander Kettner, Nathalie Dufour, Christian Frigerio, Dominique Schneeberger, Annette Leimgruber, Gampietro Corradin, François Spertini, Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial, Journal of Allergy and Clinical Immunology, 2003, 111, 4, 854

    CrossRef

  39. 39
    P. A. Wachholz, S. R. Durham, Induction of ‘blocking’ IgG antibodies during immunotherapy, Clinical & Experimental Allergy, 2003, 33, 9
  40. 40
    Petra A Wachholz, Nanna Kristensen Soni, Stephen J Till, Stephen R Durham, Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy, Journal of Allergy and Clinical Immunology, 2003, 112, 5, 915

    CrossRef

  41. 41
    Jennifer M Rolland, Robyn E O'Hehir, Allergen immunotherapy: Current and new therapeutic strategies, Allergology International, 2002, 51, 4
  42. 42
    Andrea Reimers, U. Müller, Labordiagnostik bei der Insektengift-Allergie/Laboratory Examinations in Hymenoptera Venom Allergy, LaboratoriumsMedizin, 2002, 26, 3/4, 115

    CrossRef

  43. 43
    S. M. Shuaib Nasser, Sun Ying, Qiu Meng, A. Barry Kay, Pamela W. Ewan, Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy, European Journal of Immunology, 2001, 31, 12
  44. 44
    A. J. Schuerwegh, L. S. De Clerck, C. H. Bridts, W. J. Stevens, Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes, Clinical & Experimental Allergy, 2001, 31, 5
  45. 45
    Jennifer M Rolland, Jo Douglass, Robyn E O’Hehir, Allergen immunotherapy: current and new therapeutic strategies, Expert Opinion on Investigational Drugs, 2000, 9, 3, 515

    CrossRef

  46. 46
    I. Szabó, P.A. Eigenmann, Allergenicity of major cow's milk and peanut proteins determined by IgE and IgG immunoblotting, Allergy, 2000, 55, 1
  47. 47
    F Rancé, M Abbal, F Brémont, G Dutau, Allergie aux venins d'hyménoptères chez l'enfant, Archives de Pédiatrie, 1999, 6, s55

    CrossRef

  48. 48
    Melanie Pierkes, Iris Bellinghausen, Thomas Hultsch, Gudrun Metz, Jürgen Knop, Joachim Saloga, Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells, Journal of Allergy and Clinical Immunology, 1999, 103, 2, 326

    CrossRef

  49. 49
    L. Haugaard, Immunologic effect of immunotherapy, Allergy, 1999, 54,
  50. 50
    T. Biedermann, F. Ruëff, C.A. Sander, B. Przybilla, Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels, British Journal of Dermatology, 1999, 141, 6
  51. 51
    Edith M. Janssen, Marca H. M. Wauben, Eline H. Jonker, Gerard Hofman, Willem Van Eden, Frans P. Nijkamp, Antoon J. M. Van Oosterhout, Opposite Effects of Immunotherapy with Ovalbumin and the Immunodominant T-Cell Epitope on Airway Eosinophilia and Hyperresponsiveness in a Murine Model of Allergic Asthma, American Journal of Respiratory Cell and Molecular Biology, 1999, 21, 1, 21

    CrossRef

  52. 52
    J Irsch, A Löhndorf, A Radbruch, C König, T Krieg, N Hunzelmann, H Tesch, H Merk, A Radbruch, The frequency of phospholipase A2 binding of basophilic granulocytes does not decrease during bee-venom-specific immunotherapy , Allergy, 1999, 54, 7
  53. 53
    Allergen immunotherapy: therapeutic vaccines for allergic diseases, Allergy, 1998, 53,
  54. 54
    Stephen R. Durham, Stephen J. Till, Immunologic changes associated with allergen immunotherapy, Journal of Allergy and Clinical Immunology, 1998, 102, 2, 157

    CrossRef

  55. 55
    C. André, R. Fadel, Mechanisms of allergen specific immunotherapy, Revue Française d'Allergologie et d'Immunologie Clinique, 1998, 38, 7, S227

    CrossRef

  56. 56
    M. L Kowalski, M. Jutel, Mechanisms of specific immunotherapy of allergic diseases, Allergy, 1998, 53, 5
  57. 57
    Alain Michils, Michel Mairesse, Claire Ledent, Béatrice Gossart, Sandra Baldassarre, Jean Duchateau, Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: Conversion with immunotherapy and relation to subclass expression, Journal of Allergy and Clinical Immunology, 1998, 102, 1, 118

    CrossRef

  58. 58
    J. A. Segura, M. Assenmacher, J. Irsch, N. Hunzelmann, A. Radbruch, Systemic T-cell unresponsiveness during rush bee-venom immunotherapy, Allergy, 1998, 53, 3
  59. 59
    Egner, Ward, Brown, Ewan, The frequency and clinical significance of specific IgE to both wasp (Vespula) and honey-bee (Apis) venoms in the same patient, Clinical & Experimental Allergy, 1998, 28, 1
  60. 60
    C. M. Jung, A. Funk, J. Rakoski, J. Ring, Immunohistochemical analysis of late local skin reactions during rush venom immunotherapy., Allergy, 1997, 52, 7
  61. 61
    C. EBNER, U. SIEMANN, B. BOHLE, M. WILLHEIM, U. WIEDERMANN, S. SCHENK, F. KLOTZ, H. EBNER, D. KRAFT, O. SCHEINER, Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phi p 1, a major grass pollen allergen, Clinical & Experimental Allergy, 1997, 27, 9
  62. 62
    Iris Bellinghausen, Gudrun Metz, Alexander H. Enk, Steffen Christmann, JÜRgen Knop, Joachim Saloga, Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects, European Journal of Immunology, 1997, 27, 5
  63. 63
    C. Ponvert, J. Paupe, P. Scheinmann, La désensibilisation aux venins d'hyménoptères chez l'enfant, Revue Française d'Allergologie et d'Immunologie Clinique, 1997, 37, 8, 1070

    CrossRef

  64. 64
    R. REE, W. A. LEEUWEN, P. H. DIEGES, R. GERTH WUK, N. JONG, P. Z. BREWCZYSKI, A. M. KROON, P. P. M. SCHILTE, K. Y. TAN, I. F. SIMON-LICHT, A. M. ROBERTS, S. O. STAPEL, R. C. AALBERSE, Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy, Clinical & Experimental Allergy, 1997, 27, 1
  65. 65
    A. Tsicopoulos, H. Akoum, A.-B. Tonnel, Mécanismes immunologiques de la désensibilisation, Revue Française d'Allergologie et d'Immunologie Clinique, 1997, 37, 6, 757

    CrossRef

  66. 66
    J. C. GARCÍA-ROBAINA, F. TORRE-MORÍN, C. VAZQUEZ-MONCHOLI, J. FIERRO, C. BONNET-MORENO, The natural history of Apis-specific IgG and IgG4 in beekeepers, Clinical & Experimental Allergy, 1997, 27, 4
  67. 67
    A. MICHILS, C. LEDENT, M. MAIRESSE, B. GOSSART, J. DUCHATEAU, Wasp venom immunotherapy changes IgG antibody specificity, Clinical & Experimental Allergy, 1997, 27, 9
  68. 68
    S. Jeep, M. Paul, U. Müller, G. Kunkel, Honeybee venom allergy: immunoblot studies in allergic patients after immunotherapy and before sting challenge, Allergy, 1996, 51, 8
  69. 69
    S. Jeep, M. Paul, U. Müller, G. Kunkel, Honeybee venom allergy: immunoblot studies in allergic patients after immunotherapy and before sting challenge, Allergy, 1996, 51, 8, 540

    CrossRef

  70. 70
    L. Haugaard, Immunologic effect of immunotherapy, Allergy, 1996, 54, s58, 56

    CrossRef

  71. 71
    MAREK JUTEL, U. R. MÜLLER, M. ERICKER, S. RIHS, W. J. PICHLER, C. DAHINDEN, Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils, Clinical & Experimental Allergy, 1996, 26, 10
  72. 72
    F. Ruëff, B. Przybilla, U. Müller, H. Mosbech, Position paper The sting challenge test in Hymenoptera venom allergy., Allergy, 1996, 51, 4, 216

    CrossRef

  73. 73
    POSTERS DISCUSSION SESSIONS: WEDNSEDAY, JUNE 5, 1996, Allergy, 1996, 51,
    Direct Link:
  74. 74
    Cl Ponvert, Present concepts of the mechanisms of hyposensitization, Revue Française d'Allergologie et d'Immunologie Clinique, 1996, 36, 7, 782

    CrossRef

  75. 75
    F. Ruëff, B. Przybilla, U. Müller, H. Mosbech, The sting challenge test in Hymenoptera venom allergy Position paper of the subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology, Allergy, 1996, 51, 4
  76. 76
    Y. Yu, A. L. Weck, B. M. Stadler, U. Müller, Anti-IgE autoantibodies and bee-sting allergy, Allergy, 1995, 50, 2
  77. 77
    S. M. McHUGH, J. DEIGHTON, A. G. STEWART, P. J. LACHMANN, P. W. EWAN, Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy, Clinical & Experimental Allergy, 1995, 25, 9
  78. 78
    B. EBERLEIN-KÖNIG, S. ULLMANN, P. THOMAS, B. PRZYBILLA, Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization , Clinical & Experimental Allergy, 1995, 25, 8
  79. 79
    M. JUTEL, D. SKRBIC, W. J. PICHLER, U. R. MÜLLER, Ultra rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate, Clinical & Experimental Allergy, 1995, 25, 12
  80. 80
    A. B. Wilson, J. Deighton, P. J. Lachmann, P. W. Ewan, A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom, Allergy, 1994, 49, 4
  81. 81
    C. Ebner, D. Kraft, H. Ebner, Booster immunotherapy (BIT), Allergy, 1994, 49, 1
  82. 82
    Peter-Willem G. van der Linden, C.Erik Hack, Albert Struyvenberg, J.Kees van der Zwan, Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis, Journal of Allergy and Clinical Immunology, 1994, 94, 2, 151

    CrossRef

  83. 83
    van der Linden, Hack, Struyvenberg, van der Zwan, Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: Current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis, Journal of Allergy and Clinical Immunology, 1994, 94, 2, 151

    CrossRef

  84. 84
    J. Birnbaum, D. Charpin, D. Vervloet, Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols, Revue Française d'Allergologie et d'Immunologie Clinique, 1994, 34, 4, 344

    CrossRef

  85. 85
    M. Wyss, T. Scheitlin, B. M. Stadler, B. Wüthrich, Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years, Allergy, 1993, 48, 2
  86. You have free access to this content86
    U. Mailer, H. Mosbech, Position Paper: Immunotherapy with Hymenoptera venoms, Allergy, 1993, 48,
  87. 87
    J. BIRNBAUM, D. CHARPIN, D. VERVLOET, Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols, Clinical & Experimental Allergy, 1993, 23, 3
  88. 88
    References, Clinical & Experimental Allergy, 1993, 23,
  89. 89
    P. W. EWAN, J. DEIGHTON, A. B. WILSON, P. J. LACHMANN, Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings, Clinical & Experimental Allergy, 1993, 23, 8
  90. 90
    S. JEEP, U. MEYSEL, G. KUNKEL, IgE, IgG, IgG1 and IgG4 patterns in yellow jacket allergic patients during immunotherapy with a venom depot extract, Clinical & Experimental Allergy, 1992, 22, 2
  91. 91
    Robert E. Reisman, Should routine measurements of serum venom-specific IgG be a standard of practice in patients receiving venom immunotherapy?, Journal of Allergy and Clinical Immunology, 1992, 90, 3, 282

    CrossRef

  92. 92
    L. MACCHIA, M. F. CAIAFFA, G. DI FELICE, C. PINI, G. BARILETTO, S. STRADA, A. TURSI, Changes in skin reactivity, specific IgE and IgG levels after one year of immunotherapy in olive pollinosis, Allergy, 1991, 46, 6
  93. 93
    L. Macchia, M. F. Caiaffa, G. Di Felice, C. Pini, G. Bariletto, S. Strada, A. Turn, Changes in skin reactivity, specific IgE and IgG levels after one year of immunotherapy in olive pollinosis, Allergy, 1991, 46,
  94. 94
    T. NAKAGAWA, The role of IgG subclass antibodies in the clinical response to immunotherapy in allergic disease, Clinical & Experimental Allergy, 1991, 21, 3
  95. 95
    Robert J Boyle, Mariam Elremeli, Juliet Hockenhull, Mary Gemma Cherry, Max K Bulsara, Michael Daniels, J.N.G. Oude Elberink, Venom immunotherapy for preventing allergic reactions to insect stings, The Cochrane Library,